Understanding Nanoparticle Uptake in Human Corneal Epithelial Cells: Insights into Physicochemical Determinants

Study Background and Research Question

Drug delivery to the eye remains a significant challenge in ophthalmology, largely due to the formidable barriers presented by the ocular surface. Topical ophthalmic formulations—while widely used—often suffer from low bioavailability because the tear film and corneal epithelium impede efficient drug absorption. The corneal epithelium, in particular, acts as the principal barrier, with its tightly packed cell layers and dynamic mucus environment. In this context, nanoparticle-based delivery systems have emerged as promising vehicles for enhancing ocular drug penetration. Yet, a critical knowledge gap persists: how exactly do the physicochemical properties of nanoparticles, such as size and surface chemistry, influence their uptake by corneal cells? Addressing this question is essential for the rational design of next-generation ophthalmic nanomedicines.

Key Innovation from the Reference Study

The reference study by Azadi and David (ACS Biomater. Sci. Eng., 2024) provides a mechanistic dissection of how nanoparticle size and surface modifications impact their interactions with human corneal epithelial cells (HCECs). By systematically evaluating poly(lactic-co-glycolic acid) (PLGA) nanoparticles with different surface coatings—mucoadhesive (alginate and chitosan) and mucopenetrative (polyethylene glycol, PEG)—the authors clarify which nanoparticle features most effectively drive cellular uptake in a model closely simulating the ocular surface. Notably, the study pinpoints specific endocytic pathways responsible for nanoparticle internalization, supporting more targeted design of ocular drug delivery platforms.

Methods and Experimental Design Insights

The investigative approach centered on the synthesis of PLGA nanoparticles using the emulsion-solvent evaporation technique. Surface functionalization was achieved with either mucoadhesive polymers (alginate or chitosan) or the mucopenetrative PEG. The resulting nanoparticles were characterized for size, polydispersity, and zeta potential, producing monodisperse spherical particles with diameters ranging from 100 to 250 nm and surface charges from −25 to +15 mV.

For biological assessment, HCECs were cultured as monolayers and exposed to simulated mucosal conditions, closely mimicking the corneal epithelial barrier. Cytotoxicity was evaluated via the MTT assay, confirming that all nanoparticle formulations induced only mild toxicity at concentrations up to 100 μg/mL after 24 hours (cell viability 70–100%). Uptake studies employed fluorescently labeled nanoparticles and pharmacological inhibitors to dissect the mechanisms of internalization, focusing on energy dependence and specific endocytic pathways.

Protocol Parameters

• Nanoparticle formulation: PLGA nanoparticles (100–250 nm), surface-modified with alginate, chitosan, or PEG using emulsion-solvent evaporation.
• Cytotoxicity assessment: MTT assay after 24-hour exposure at 10–100 μg/mL nanoparticle concentration.
• Uptake studies: Fluorescent labeling of nanoparticles for quantification in HCEC monolayers; incubation with specific endocytosis inhibitors (e.g., amiloride for macropinocytosis, genistein for caveolae-mediated pathways, and chlorpromazine for clathrin-mediated endocytosis).
• Simulated mucosal environment: Integration of mucin solution to mimic tear film conditions during uptake experiments.

Core Findings and Why They Matter

The study delivers several pivotal findings that refine our understanding of ocular nanoparticle delivery. First, it confirms that energy-dependent endocytosis is the principal mechanism for nanoparticle uptake in HCECs. Importantly, both macropinocytosis and caveolae-mediated endocytosis are identified as the dominant routes—this was substantiated by significant decreases in uptake upon pharmacological inhibition of these pathways. Clathrin-mediated endocytosis contributed to uptake but played a lesser role, while phagocytosis was not implicated within the tested nanoparticle size and surface chemistry range.

From a formulation perspective, nanoparticles with smaller diameters (specifically, 100 nm PLGA NPs and PEG-PLGA-150 NPs) demonstrated the greatest cellular uptake. Surface modification with PEG enhanced mucopenetrative capacity, likely facilitating access through the dense mucus and cellular junctions characteristic of the corneal epithelium. These findings underscore the importance of tailoring both size and surface chemistry to optimize delivery—an insight highly relevant for translational ocular therapies.

Comparison with Existing Internal Articles

Two internal resources—Nanoparticle Uptake Mechanisms in Human Corneal Epithelial Cells and Nanoparticle Uptake Mechanisms in Human Corneal Epithelial Cells—corroborate the reference study’s conclusions, emphasizing that both nanoparticle size and surface properties are decisive in dictating cellular uptake routes in HCECs. These articles also highlight macropinocytosis and caveolae-mediated endocytosis as primary uptake mechanisms, consistent with the key results of Azadi and David. Furthermore, they discuss how such mechanistic insights inform the engineering of nanocarriers to maximize bioavailability and targeting precision in ocular drug delivery.

Complementary insights are also available in resources focusing on actin polymerization inhibitors, such as Cytochalasin D: Mechanistic Insights and Translational Potential and Cytochalasin D in Cell Biology: Protocols & Troubleshooting Tips. These articles explore how actin cytoskeleton modulators, including Cytochalasin D, can be leveraged to probe endocytic pathways in cellular uptake studies, highlighting their utility in dissecting the mechanistic basis of nanoparticle internalization.

Limitations and Transferability

While the study by Azadi and David offers valuable mechanistic insight, its findings are primarily based on in vitro HCEC monolayer models with simulated mucosal conditions. Although these models closely mimic the corneal barrier, they do not fully recapitulate the complex, layered structure and dynamic clearance mechanisms present in vivo. Additionally, the range of nanoparticle sizes and surface chemistries tested—while representative—does not encompass all possible nanomaterial designs relevant for ocular therapy. The lack of in vivo validation means that predictions about therapeutic performance and safety in clinical contexts should be made with caution. Nevertheless, the delineation of cellular uptake pathways remains broadly informative for researchers optimizing nanoparticle formulations for ocular, and potentially other mucosal, drug delivery routes.

Why this cross-domain matters, maturity, and limitations

The mechanistic principles uncovered in this study have implications beyond ophthalmology. Understanding how nanoparticle physicochemical properties dictate uptake via distinct endocytic pathways is relevant for broader mucosal drug delivery strategies, including pulmonary, nasal, and gastrointestinal applications. However, the transferability of these insights requires careful validation, as tissue architecture and surface mucus composition differ markedly between organs. The maturity of the field is advancing, but in vivo translation remains a challenge due to the complexity of physiological barriers and potential for off-target effects.

Research Support Resources

Researchers aiming to explore nanoparticle uptake mechanisms or to interrogate the role of endocytosis pathways in cell models can employ actin polymerization inhibitors such as Cytochalasin D (SKU B6645). As a potent and selective inhibitor of actin polymerization, Cytochalasin D is widely used to modulate cellular uptake processes and study the dynamics of endocytosis in vitro. For experimental protocols and advanced troubleshooting, internal resources such as Cytochalasin D in Cell Biology: Protocols & Troubleshooting Tips offer detailed guidance. APExBIO provides Cytochalasin D in a crystalline solid form, suitable for cell biology applications where precise inhibition of actin-dependent processes is essential for dissecting uptake mechanisms in cultured cell systems.